Agenda

*Subject to change

All times are in Eastern Time.

Day 1: Friday, September 30, 2022
All times are in ET

9:55 AM - 10:00 AM: Welcome Remarks - Marwan Sabbagh, MD, FAAN (Moderator)

10:00 AM - 11:00 AM: Targeting CGRP for the Treatment of Migraine - Nada Hindiyeh, MD (Headache Neurologist)
Migraine affects nearly 40 million people and represents the second leading cause of disability in the United States, making timely and effective treatment of major importance. In this presentation, we will review the role of calcitonin gene-related peptide (CGRP) in migraine and detail novel treatments targeting this molecule for both acute and preventive migraine treatment. 

- 5-min break -

11:05 AM - 12:05 PM: Non-CME Educational Talk
Sponsored by Neurocrine Biosciences
Understanding the Benefits of COMT Inhibition and ONGENTYS® (opicapone) Capsules for Patients With Parkinson’s Disease
Presenter: Fahd Amjad, MD, Assistant Professor of Neurology, Division of Movement Disorders/ Department of Neurology, Georgetown University Hospital

- 5-min break -

12:10 PM - 1:10 PM: Management of Neuropsychiatric Features in Alzheimer’s Disease Dementia - Marwan Sabbagh, MD, FAAN (Barrow Neurological Institute)
This presentation will discuss how to recognize the psychiatric symptoms associated with dementia, the on-label and off-label medications and strategies used in Alzheimer’s disease psychosis, and dementia-related psychosis, and new and emerging treatments for treating neuropsychiatric symptoms in Alzheimer’s disease dementia.

- 30-min break, including 5-min yoga session -

1:40 PM - 2:40 PM: A Changing Treatment Paradigm of Myasthenia Gravis: A Focus on Novel Targeted Treatments - Jonathan Katz, MD (California Pacific Medical Center) and Gil I. Wolfe, MD, FAAN (University of Buffalo)
Historically, myasthenia gravis (MG) has been treated with immunosuppressive therapy. Targeted treatments have been approved or are under investigation for MG that change the current treatment paradigm. This session will educate healthcare providers on the historical treatment of MG, how the newer agents change the treatment paradigm, and demonstrate how to treat various subtypes of MG through patient case examples.

- 5-min break -

2:45 PM - 3:45 PM: Planning Ahead: Development of a Seizure Action Plan With Rescue Medications – Jacqueline A. French, MD (NYU Grossman School of Medicine)
Adding a rescue plan and rescue therapy to an established epilepsy regimen can substantially improve outcomes. This talk will address which patients should receive rescue therapy, how to write a rescue plan, and which rescue therapies are optimal for which patients.

- 5-min break -

3:50 PM - 4:50 PM: Diagnosis and Management of Parkinson’s Disease Dementia - Marwan Sabbagh, MD, FAAN (Barrow Neurological Institute)
The presentation will discuss the cardinal features of Parkinson’s disease dementia, how it differs from dementia with Lewy bodies and Parkinson’s disease, diagnostic strategies, and pharmacologic and nonpharmacologic strategies.

4:50 PM - 4:55 PM: Closing Remarks - Marwan Sabbagh, MD, FAAN (Moderator)

Day 2: Saturday, October 1, 2022
All times are in ET

9:55 AM - 10:00 AM: Welcome Remarks - Rajesh Pahwa, MD (Chair)

10:00 AM - 11:00 AM: Distinguishing Tardive Dyskinesia From Other Drug-Induced Movement Disorders - Stuart Isaacson, MD (FIU Herbert Wertheim College of Medicine)
In this session, we will review our current understanding of tardive dyskinesia, clinical pearls to distinguish it from other drug-induced movement disorders, and how assessment of the impact of tardive dyskinesia can aid treatment decisions with first-line VMAT2 inhibitor therapy.

- 5-min break -

11:05 AM - 12:05 PM: Managing Advanced Parkinson’s Disease: Adjunctive Therapies - Rajesh Pahwa, MD (University of Kansas Medical Center)
This session will focus on patients with Parkinson’s disease, motor fluctuation, and dyskinesia and the use of adjunctive therapies to levodopa to improve their OFF time and improve their good time during the day.

- 5-min break -

12:10 PM - 1:10 PM: Hyperkinetic Movement Disorders: Importance of Differential Diagnosis When Symptoms Overlap - Victor Sung, MD (University of Alabama School of Medicine at Birmingham)
This session will discuss the various hyperkinetic movements and will provide a framework to differentiate among the various disorders that cause them. In addition, a treatment algorithm will be discussed for the specific hyperkinetic movement of chorea caused by Huntington’s disease.

- 30-min break, including 5-min yoga session -

1:40 PM - 2:40 PM: Beyond Pharmacotherapy: Advancements in Surgical Therapies for Parkinson’s Disease - Marta San Luciano, MD (University of California San Francisco)
In this session, Dr. San Luciano will discuss the indications and appropriateness for surgical therapies in Parkinson’s disease. She will review the procedure, outcomes, benefit/risks, and current state of research of deep brain stimulation, carbidopa/levodopa intestinal gel therapy, and high frequency MR-guided focused ultrasound.

- 5-min break -

2:45 PM - 3:45 PM: Updates in Diagnosis and Treatment of Essential Tremor - Daniel E. Kremens, JD, MD (Thomas Jefferson University)
In this session, Dr. Kremens will review essential tremor, including the epidemiology and recent diagnostic criteria. He also will review current and emerging treatments for essential tremor including pharmacologic, surgical, and device-aided therapies.

3:45 PM - 3:50 PM: Closing Remarks - Rajesh Pahwa, MD (Chair)